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For the treatment of severe listeriosis a combination of 
ampicillin and an aminoglycoside is recommended, 
with tetracyclines, erythromycin, chloramphenicol, 
vancomycin and co-trimoxazole as possible alternatives 
[I]. Listeria rnonocytogenes is constitutively resistant to 
the cephalosporins, nalidixic acid and polymyxin E but 
resistance to ampicillin has not been observed in this 
bacterium [2]. High resistance to tetracyclines (MIC 
262.5 mg/L) has been reported in a few strains [2], but 
in the UK the incidence of tetracycline resistance has 
remained constant over the past 30 years, with between 
2% and 5% of isolates resistant to this antibiotic 13-51, 
Following a recent report from Greece of neonatal 
meningitis due to a multiresistant strain of L. mono- 
cytogenes [6] and reports of multiresistance in cultures 
from clinical cases in France [7, 81 and Switzerland [9], 
we screened 773 isolates of L. rnonocytogenes comprising 
85 from cases of human listeriosis obtained in 1996, and 
688 from foods, isolated between 1970 and 1996, for 
resistance to antibiotics. All isolations were made in the 
UK. Isolates were screened by an agar dilution 
breakpoint method [lo] for resistance to ampicillin (A), 
chloramphenicol (C), colistin (Co), erythromycin (E), 
gentaniicin (G), kanamycin (K), streptomycin (S), 
spectinomycin (Sp), sulfonamides (Su), tetracyclines 
(T), trimethoprim (Tm), vancomycin (V), furazolidone 
(Fu), nalidixic acid (Nx) and ciprofloxacin (Cp). The 
levels of antibiotics incorporated into the plates were 
(mg/L): A, 8; C, 8; Co, 8; E, 0.5; G, 4; K, 16; S, 16; 
Su, 64; Sp, 64; T, 8; Tm, 2; V, 4; Fu, 8; Nx, 16; Cp, 
0.125 and 1.0. With the exception of Cp  0.125, the 
levels of antimicrobial were either equal to or greater 
than the levels recommended by the British Society of 
Antimicrobial Chemotherapy [l 11. For isolates 
showing additional resistance to tetracyclines and 
ciprofloxacin, the full minimal inhibitory concen- 
trations (MICs) for the respective antimicrobials were 
determined by a doubling dilution series in Isosensitest 
agar. Data for human isolates received in 1996 were 
compared to those obtained in previous studies (3-51. 
All of the isolates showed typical resistance 
patterns, i.e. constitutive resistance, to the cephalo- 
sporins, nalidixic acid and polymyxins. However, three 
of 85 (3.6%) isolates from humans were additionally 
resistant either to ciprofloxacin (MIC 22.0 mg/L) (one 
isolate) or tetracyclines (MIC 2 16 mg/L) (two 
isolates), and 15 of 688 (2.2%) isolates from foods were 
additionally resistant to ciprofloxacin (MIC 22 .0  mg/L) 
(10 isolates), tetracyclines (three isolates), erythromycin 
(MIC 2 1 .O mg/L) (one isolate) or trimethoprim (MIC 
Table 1 Antibiotic resistance in Listeria monocytqenes from humans and food 
~~ 
Human isolates Food isolates 
Year No. screened T' CP' No. tested CP' T' E' Tm' 
1996 85 2 1 114 1 - 1 
1995 87 2 
1994 85 1 
1993 18 
1992 10 
1991 78 1 
1990 35 2 
1989 73 
1988 50 1 
1987 38 2 
1972 6 1 
1971 80 1 
1970 14 
3 
Totals 85 2 1 688 10 3 1 1 
Cp, ciprofloxacin (MIC 2 2  mg/L); E, erythromycin (MIC 2 1  mg/L); T, tetracycline (MIC 216 mg/L); 
Tm, trimethoprim (MIC 2 4  mg/L). 
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24 mg/L) (one isolate) (Table 1). For isolates with 
additional resistance to ciprofloxacin, the MICs ranged 
from 4.0 to 8.0 mg/L, and for isolates resistant to 
tetracyclines, the MICs ranged from 32 to 125 mg/L. 
All isolates with additional non-constitutive resistances 
were screened for plasmid DNA by standard methods 
[12], but no covalently closed circular DNA was 
detected. 
Previous studies of resistance in human clinical 
isolates of L. monocytogenes obtained between 1967 and 
1995 demonstrated an incidence of resistance to tetra- 
cyclines of between 2% and 5%; resistance to other 
antimicrobials was extremely rare [3-51, although in 
two surveys resistance to ciprofloxacin was detected in 
a small number of isolates [2,5]. The results of the 
current study have demonstrated that in the UK, with 
the exception of constitutive resistance to cephalo- 
sporins, nalidixic acid and polymyxins, antibiotic 
resistance has remained uncommon in human isolates 
of L. monocytogenes and is also rare in isolates from food. 
This is particularly relevant to human listeriosis, as it is 
generally believed that the consumption of con- 
taminated food is the principal route of transmission 
The results of this investigation, which to our 
knowledge is the first comprehensive survey of the 
occurrence of antibiotic resistance in isolates of L. 
monocytogenes from food in the UK, are in accordance 
with those of MacGowan et al. [2] and Johnson et al. 
[5]. However, it is noteworthy that in our study 
resistance to ciprofloxacin at levels above the anti- 
cipated serum level of 2.0-4.0 mg/L was identified in 
10 isolates from food, two of which were isolated 
before the 1980s, which was when this antibiotic 
became available for clinical use in the UK. As all 
isolates of L. monocytogenes are intrinsically resistant to 
nalidixic acid, it is possible that resistance to cipro- 
floxacin has resulted from an additional spontaneous 
mutation in the gyrA gene in this organism. It should 
be noted that, because of the limited cerebrospinal fluid 
diffusion of ciprofloxacin [14], this antimicrobial has 
not been recommended for the treatment of human 
listeriosis. 
Antibiotic resistance genes common to L. mono- 
cytogenes and other Gram-positive organisms have been 
described [15-171 and plasmids conferring resistance to 
chloramphenicol, erythromycin, streptomycin and 
tetracycline have recently been described in clinical 
isolates from Greece, France and Switzerland [6-9). L. 
monocytogenes is common in the environment and 
occurs in the intestinal tracts of a wide variety of 
animals; the organism has also been recovered from the 
feces of healthy individuals [ 18,191. Antibiotic resist- 
ance remains rare in L. monocytogenes, but given that 
(131. 
there is potential for the acquisition of antibiotic 
resistance genes from other species of bacteria [20] and 
to antibiotic selective pressure in both animal and 
human hosts, it is both surprising and reassuring that in 
the UK there is not more antibiotic resistance in this 
organism in isolates from both humans and food. 
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Failure to detect Helicobacfer pylori in vaginal secretions 
CIin Microbiol Itzfect 1998; 4: 412-413 
The exact source of Helicobacter pylori infection and its 
mode of transmission are among the greatest mysteries 
in the epidemiology of this microorganism. The 
recovery of H .  pylori from gastric secretions, saliva, 
dental plaque and feces strongly supports person-to- 
person transmission. Nevertheless, little information is 
available on the possibility of sexual transmission of this 
microorganism. Although pioneer studies suggested 
that sexual intercourse may enhance colonization with 
this organism [ 11, more recent epidemiologic studies 
have not found evidence of sexual transmission of 
H.  pylori [2,3]. To date, no investigation has been 
conducted to determine the presence of H .  pylori in 
sexual secretions. In this investigation, we attempted to 
recover H .  pylori from vaginal secretions, as their acid 
pH renders them similar to the gastric environment, the 
natural reservoir of this microorganism. 
An investigation was carried out in a group of 106 
consecutive females (mean age: 46 (SD 14.8 years) who 
attended regular annual gynecologic examinations in 
the outpatient clinic of our hospital between December 
1996 and March 1997. All of them completed a 
questionnaire, including personal and family data on 
previous history of peptic ulcer disease, pregnancy, 
regular use of sanitary towels or tampons, regular use of 
vaginal medical preparations, frequency of sexual 
intercourse and use of contraceptive methods (type). 
During vaginal examination, two vaginal brushings 
were routinely taken: from the middle third of the 
vagina and from the vaginal vault. In addition, p H  was 
measured at each site. 
Vaginal brushings were inoculated with a swab 
onto Pylori Agar plates (BioMkrieux, France) and 
incubated at  37OC, under micro-aerophilic conditions 
(Campypack plus, BBL) for 7 days. In addition, vaginal 
brushings were homogenized in 0.5 mL of sterile 
distilled water. From this homogenate, 0.1 mL was used 
for DNA extraction following sodium dodecylsulfate 
(SDS) lysis, cetyl trimethyl ammonium bromide 
(CTAB) precipitation, and phenol/chloroform extrac- 
tion, in the procedure previously described [4], and 
resuspension in 60 pL sterile water. With every ten 
samples from the subjects three different positive 
controls were included. These were prepared by the 
addition to homogenized brushings of: H .  pylori 
colonies from a standard culture, previously extracted 
H .  pylori DNA, and 0.05 mL of gastric contents, from 
a patient, which were polymerase chain reaction (PCR) 
positive for H. pylori. After the addition of H. pylori to 
the samples, DNA was extracted following the above 
method. 
To detect H .  pylori by the P C R  procedure, a 356- 
bp fragment belonging in the ureA gene was 
investigated by using the primers and conditions 
previously described [5]: A 5'-CCA AAA GAG TTA 
GAG AAG TTG ATG-3', and C 5'-CC TTC GTT 
GAT AGT GAT GTC TTC-3'; 2 m M  M$+, 
bufferx 1, 200 pmol of each dNTP, 0.1 pmol of each 
primer, 4 pL of extracted DNA and 2 U of Taq DNA 
polymerase (Gibco, BRL) were added in a final 
reaction volume of 0.1 mL, and covered with 0.1 mL 
of mineral oil. The amplification conditions comprised 
50 cycles with the following temperatures each cycle: 
95°C for 1 min, 60OC for 2 min, and 72°C for 2 min. 
Amplified products were electrophoresed in a 2% 
agarose gel and stained with ethidium bromide. 
Twenty-one of 106 (1 9.8%) females reported 
previous peptic ulcer disease; 47 of 106 (44.3%) 
reported having relatives with such a history. Fifteen of 
106 (14.3%) females were pregnant. Sanitary towels 
and tampons were regularly used by 22 of 106 (20.8%) 
and 81 (76.4%) females, respectively. Three of 106 
(2.8%) reported regular use of vaginal medical prepara- 
tions. Sixty-nine (65.1%) reported sexual intercourse 
